Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Revisão |
| Reo: | Ingarihi |
| I whakaputaina: |
2020
|
| Urunga tuihono: | https://doi.org/10.1080/14737159.2020.1768849 |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|